Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction

References

1. 1.↵
   2. Lassmann H,
   3. Brück W,
   4. Lucchinetti CF

   . The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17:210–18 doi:10.1111/j.1750-3639.2007.00064.x pmid:17388952

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Gilmore CP,
   3. Donaldson I,
   4. Bö L, et al

   . Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009;80:182–87 doi:10.1136/jnnp.2008.148767 pmid:18829630

   Abstract/FREE Full Text
3. 3.↵
   2. Vercellino M,
   3. Masera S,
   4. Lorenzatti M, et al

   . Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009;68:489–502 doi:10.1097/NEN.0b013e3181a19a5a pmid:19525897

   CrossRefPubMed
4. 4.↵
   2. Haider L,
   3. Simeonidou C,
   4. Steinberger G, et al

   . Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386–95 doi:10.1136/jnnp-2014-307712 pmid:24899728

   Abstract/FREE Full Text
5. 5.↵
   2. Stephenson E,
   3. Nathoo N,
   4. Mahjoub Y, et al

   . Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat Rev Neurol 2014;10:459–68 doi:10.1038/nrneurol.2014.118 pmid:25002107

   CrossRefPubMed
6. 6.↵
   2. Bakshi R,
   3. Benedict RH,
   4. Bermel RA, et al

   . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68 doi:10.1001/archneur.59.1.62 pmid:11790232

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Ge Y,
   3. Jensen JH,
   4. Lu H, et al

   . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639–44 doi:10.3174/ajnr.A0646 pmid:17893225

   Abstract/FREE Full Text
8. 8.↵
   2. Burgetova A,
   3. Seidl Z,
   4. Krasensky J, et al

   . Multiple sclerosis and the accumulation of iron in the basal ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol 2010;63:136–43 doi:10.1159/000279305 pmid:20130410

   CrossRefPubMed
9. 9.↵
   2. Khalil M,
   3. Langkammer C,
   4. Ropele S, et al

   . Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691–97 doi:10.1212/WNL.0b013e318236ef0e pmid:21975210

   CrossRefPubMed
10. 10.↵
    2. Rudko DA,
    3. Solovey I,
    4. Gati JS, et al

    . Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging. Radiology 2014;272:851–64 doi:10.1148/radiol.14132475 pmid:24828000

    CrossRefPubMed
11. 11.↵
    2. MacKay A,
    3. Whittall K,
    4. Adler J, et al

    . In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 1994;31:673–77 doi:10.1002/mrm.1910310614 pmid:8057820

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Deoni SCL,
    3. Rutt BK,
    4. Arun T, et al

    . Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn Reson Med 2008;60:1372–87 doi:10.1002/mrm.21704 pmid:19025904

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Hwang D,
    3. Kim DH,
    4. Du YP

    . In vivo multi-slice mapping of myelin water content using T2* decay. Neuroimage 2010;52:198–204 doi:10.1016/j.neuroimage.2010.04.023 pmid:20398770

    CrossRefPubMed
14. 14.↵
    2. Glasser MF,
    3. Van Essen DC

    . Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci 2011;31:11597–616 doi:10.1523/JNEUROSCI.2180-11.2011 pmid:21832190

    Abstract/FREE Full Text
15. 15.↵
    2. Yarnykh VL

    . Pulsed Z-spectroscopic imaging of cross-relaxation parameters in tissues for human MRI: theory and clinical applications. Magn Reson Med 2002;47:929–39 doi:10.1002/mrm.10120 pmid:11979572

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Yarnykh VL

    . Fast macromolecular proton fraction mapping from a single off-resonance magnetization transfer measurement. Magn Reson Med 2012;68:166–78 doi:10.1002/mrm.23224 pmid:22190042

    CrossRefPubMed
17. 17.↵
    2. Yarnykh VL

    . Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping. Magn Reson Med 2016;75:2100–06 doi:10.1002/mrm.25811 pmid:26102097

    CrossRefPubMed
18. 18.↵
    2. Yarnykh VL,
    3. Bowen JD,
    4. Samsonov A, et al

    . Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis. Radiology 2015;274:210–20 doi:10.1148/radiol.14140528 pmid:25208343

    CrossRefPubMed
19. 19.↵
    2. Petrie EC,
    3. Cross DJ,
    4. Yarnykh VL, et al

    . Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans. J Neurotrauma 2014;31:425–36 doi:10.1089/neu.2013.2952 pmid:24102309

    CrossRefPubMed
20. 20.↵
    2. Ou X,
    3. Sun SW,
    4. Liang HF, et al

    . The MT pool size ratio and the DTI radial diffusivity may reflect the myelination in shiverer and control mice. NMR Biomed 2009;22:480–87 doi:10.1002/nbm.1358 pmid:19123230

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Underhill HR,
    3. Rostomily RC,
    4. Mikheev AM, et al

    . Fast bound pool fraction imaging of the in vivo rat brain: association with myelin content and validation in the C6 glioma model. Neuroimage 2011;54:2052–65 doi:10.1016/j.neuroimage.2010.10.065 pmid:21029782

    CrossRefPubMed
22. 22.↵
    2. Thiessen JD,
    3. Zhang Y,
    4. Zhang H, et al

    . Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination. NMR Biomed 2013;26:1562–81 doi:10.1002/nbm.2992 pmid:23943390

    CrossRefPubMed
23. 23.↵
    2. Turati L,
    3. Moscatelli M,
    4. Mastropietro A, et al

    . In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice. NMR Biomed. 2015;28:327–37 doi:10.1002/nbm.3253 pmid:25639498

    CrossRefPubMed
24. 24.↵
    2. Khodanovich MY,
    3. Sorokina IV,
    4. Glazacheva VY, et al

    . Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model. Sci Rep 2017;7:46686 doi:10.1038/srep46686 pmid:28436460

    CrossRefPubMed
25. 25.↵
    2. Li K,
    3. Li H,
    4. Zhang XY, et al

    . Influence of water compartmentation and heterogeneous relaxation on quantitative magnetization transfer imaging in rodent brain tumors. Magn Reson Med 2016;76:635–44 doi:10.1002/mrm.25893 pmid:26375875

    CrossRefPubMed
26. 26.↵
    2. Fischer JS,
    3. Rudick RA,
    4. Cutter GR, et al

    . The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment—National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244–50 pmid:10467383

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Yarnykh VL

    . Optimal radiofrequency and gradient spoiling for improved accuracy of T1 and B1 measurements using fast steady-state techniques. Magn Reson Med 2010;63:1610–26 doi:10.1002/mrm.22394 pmid:20512865

    CrossRefPubMed
28. 28.↵
    2. Skinner TE,
    3. Glover GH

    . An extended two-point Dixon algorithm for calculating separate water, fat, and B0 images. Magn Reson Med 1997;37:628–30 doi:10.1002/mrm.1910370426 pmid:9094088

    CrossRefPubMed
29. 29.↵
    2. Yarnykh VL

    . Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med 2007;57:192–200 doi:10.1002/mrm.21120 pmid:17191242

    CrossRefPubMed
30. 30.↵
    2. Miller AJ,
    3. Joseph PM

    . The use of power images to perform quantitative analysis on low SNR MR images. Magn Reson Imaging 1993;11:1051–56 doi:10.1016/0730-725X(93)90225-3 pmid:8231670

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Neema M,
    3. Arora A,
    4. Healy BC, et al

    . Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009;19:3–8 doi:10.1111/j.1552-6569.2008.00296.x pmid:19192042

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Walsh AJ,
    3. Blevins G,
    4. Lebel RM, et al

    . Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 2014;270:186–96 doi:10.1148/radiol.13130474 pmid:23925273

    CrossRefPubMed
33. 33.↵
    2. Haacke EM,
    3. Cheng NY,
    4. House MJ, et al

    . Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25 doi:10.1016/j.mri.2004.10.001 pmid:15733784

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Sadrzadeh SM,
    3. Saffari Y

    . Iron and brain disorders. Am J Clin Pathol 2004;121(Suppl):S64–70 pmid:15298151

    PubMed
35. 35.↵
    2. Stüber C,
    3. Morawski M,
    4. Schäfer A, et al

    . Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage 2014;93(Pt 1):95–106 doi:10.1016/j.neuroimage.2014.02.026 pmid:24607447

    CrossRefPubMed
36. 36.↵
    2. Sun H,
    3. Walsh AJ,
    4. Lebel RM, et al

    . Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. Neuroimage 2015;105:486–92 doi:10.1016/j.neuroimage.2014.11.010 pmid:25462797

    CrossRefPubMed